Literature DB >> 2108015

Longitudinal clinicoelectrophysiologic study of a case of Lafora disease proven by skin biopsy.

K Kobayashi1, K Iyoda, Y Ohtsuka, S Ohtahara, M Yamada.   

Abstract

A longitudinal clinicoelectrophysiologic study was undertaken of a 15-year 2-month-old girl with Lafora disease who was diagnosed by skin biopsy and an immunohistochemical method with antisera against Lafora bodies. From age 10 years 5 months, 4 months after onset, EEG disclosed progressive deterioration of background activity and incremental increase in epileptic discharges. Photosensitivity was unique: Occipital spikes and diffuse spike-wave discharges were provoked by low-frequency repetitive photic stimuli but without elicitation of myoclonic seizures. Photosensitivity completely disappeared after age 13 years 10 months. High-voltage somatosensory evoked potentials (SEPs) and high-voltage flash visual evoked potentials (F-VEPs) were seen before age 13. After age 13, progressive prolongation of I-III and I-V interpeak latencies of auditory brainstem responses (ABRs), progressive prolongation of latencies of photoevoked eyelid microvibrations, delayed latencies of pattern-reversal visual evoked potentials, and a decrease in the V/I amplitude ratio of ABRs and the previously high F-VEP amplitudes were observed.

Entities:  

Mesh:

Year:  1990        PMID: 2108015     DOI: 10.1111/j.1528-1167.1990.tb06306.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

Review 1.  Lafora disease: epidemiology, pathophysiology and management.

Authors:  Thomas S Monaghan; Norman Delanty
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 2.  Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects.

Authors:  Luis Felipe Mendonça de Siqueira
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

3.  Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.

Authors:  Shweta Singh; Toshimitsu Suzuki; Akira Uchiyama; Satoko Kumada; Nobuko Moriyama; Shinichi Hirose; Yukitoshi Takahashi; Hideo Sugie; Koichi Mizoguchi; Yushi Inoue; Kazue Kimura; Yukio Sawaishi; Kazuhiro Yamakawa; Subramaniam Ganesh
Journal:  J Hum Genet       Date:  2005-07-15       Impact factor: 3.172

Review 4.  Lafora disease, seizures and sugars.

Authors:  D M Andrade; J Turnbull; B A Minassian
Journal:  Acta Myol       Date:  2007-07

5.  Posterior paroxysmal discharge: an aid to early diagnosis in Lafora disease.

Authors:  S Ponsford; I F Pye; E J Elliot
Journal:  J R Soc Med       Date:  1993-10       Impact factor: 5.344

6.  Early detection of skin and muscular involvement in Lafora disease.

Authors:  S Iannaccone; M Zucconi; A Quattrini; R Nemni; M Comola; L Taccagni; S Smirne
Journal:  J Neurol       Date:  1991-07       Impact factor: 4.849

7.  Diagnosis by axilla skin biopsy in an early case of Lafora's disease.

Authors:  G Rubio; C Garcia Guijo; J J Mallada; A Cabello; A Garcia Merino
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

Review 8.  Progressive myoclonic epilepsy.

Authors:  Mary L Zupanc; Benjamin Legros
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.